Literature DB >> 18680776

Vaccination against Marek's disease reduces telomerase activity and viral gene transcription in peripheral blood leukocytes from challenged chickens.

Manel Debba-Pavard1, Aouatef Ait-Lounis, Denis Soubieux, Denis Rasschaert, Ginette Dambrine.   

Abstract

We investigated whether telomerase activity and viral gene transcription were associated with protection against the RB-1B strain of Marek's disease virus (MDV) in chickens vaccinated with Rispens CVI988 or the herpes virus of turkey (HVT). Telomerase activity in peripheral blood leukocytes (PBLs) seemed to be an appropriate marker of lymphoma and levels of viral transcription were correlated with the virulence of MDV strains. Vaccinated protected birds had lower levels of telomerase activity and RB-1B viral gene transcription than unvaccinated chickens infected with RB-1B. The decrease in RB-1B viral transcription was more marked in chickens vaccinated with CVI988 than in those vaccinated with HVT. Indeed, RB-1B viral transcription was not detectable after 14 days post-challenge. In conclusion, telomerase activity and gene transcription in challenge MDV strains are potential new reliable criteria of protection in vaccinated chickens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18680776     DOI: 10.1016/j.vaccine.2008.07.038

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  The oncogenic microRNA OncomiR-21 overexpressed during Marek's disease lymphomagenesis is transactivated by the viral oncoprotein Meq.

Authors:  Grégoire Stik; Ginette Dambrine; Sébastien Pfeffer; Denis Rasschaert
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

2.  Alternative splicing and nonsense-mediated decay regulate telomerase reverse transcriptase (TERT) expression during virus-induced lymphomagenesis in vivo.

Authors:  Souheila Amor; Sylvie Remy; Ginette Dambrine; Yves Le Vern; Denis Rasschaert; Sylvie Laurent
Journal:  BMC Cancer       Date:  2010-10-21       Impact factor: 4.430

3.  Epigenetic Silencing of MicroRNA-126 Promotes Cell Growth in Marek's Disease.

Authors:  Isabelle Gennart; Astrid Petit; Laetitia Wiggers; Srđan Pejaković; Nicolas Dauchot; Sylvie Laurent; Damien Coupeau; Benoît Muylkens
Journal:  Microorganisms       Date:  2021-06-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.